Navigation Links
Force EZ Electrosurgical Generator

ProductsForce EZ Electrosurgical Generator
Company Valleylab
Item Force EZ Electrosurgical Generator
Features The Force EZ generator uses Instant Response technology - to ensure consistent clinical performance using less power. Cutting, coagulating and bipolar outputs are designed for a wide range of surgical applications. Select from two cut modes, two coag modes and a bipolar mode to achieve the desired surgical effect. Valleylab REM system reduces the risk of patient burns at the return electrode site. Two cut modes offer a choice of pure for a clean, precise cut in any tissue, and blend for cutting with hemostasis. Two coag modes let you choose between low (desiccate) and high (fulgurate). Use high for efficient noncontact coagulation in most applications, and for argon-enhanced electrosurgery. Select low for rapid contact coagulation and laparoscopic procedures. Bipolar mode utilizes low voltage to minimize sticking and charring of tissue. Additional safety features include dosage error power monitor and leakage current controller. Lower voltage reduces sparking, neuromuscular stimulation and RF interference.
Description Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology.
Info Valleylab
Customer Service: (800) 255-8522
Web site: http://www.valleylab.com/

Related medicine products :

1. Ostrum Antrum Punch Forceps
2. Storz Antrum Punch Forceps
3. Sidebiting Antrum Punch Forceps
4. Pediatric Ostrum Antrum Punch Forceps
5. Rotating Ostrum Antrum Punch Forceps
6. Pediatric Rotating Ostrum Antrum Punch Forceps
7. Force FX Electrosurgical Generator
8. Force Generator
9. Force 1C Generator
10. Force 2 Generator
11. McPherson Straight Bipolar Forceps
Breaking Medicine Technology:Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 1NASA Research Reveals Major Insight Into Evolution of Life on Earth 4870 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 1The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 2The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 3The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 54897 4Patch Shots May Someday Replace Injections 54893 1Patch Shots May Someday Replace Injections 54893 2